Market Research Logo

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)

Human Growth Hormone (hGH) is a peptide hormone produced by the pituitary gland that stimulates growth in children and adults. It plays an important role in the functioning of the human body by regulating body fluids, muscle and bone growth and fat metabolism of the body. The deficiency of growth hormone in the body is known as growth hormone deficiency which is administered by intramuscular or subcutaneous GH injections on a daily basis. Various therapeutics products are currently in the final phase of development and are expected to be launched in the coming years.

The market is expected to experience robust growth due to the increasing prevalence of GH and long-acting growth hormone formulations in development. Rising aging population accompanied by high growth of serious chronic diseases would keep the demand for hGH drugs high and would act as the growth catalyst for the global market.

The global long-acting growth hormone market is estimated to increase at a commendable rate in future, which is mainly due to increase in research and development activities and increasing occurrence of pituitary dysfunction. TransCon is expected to dominate the market due to ease of use and high efficacy. The market will see a shift in the use of long-acting hormone drugs from daily basis products, positively impacting the market.

Geographically, the U.S. dominated the market owing to its advance healthcare infrastructure. Majority of the players are based in the U.S., thus leading to the highest revenue from this region. The U.S. human growth hormone market is anticipated to grow at a steady rate owing to high research and development efforts.

The report “Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2019-2023)” analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have been profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global market along with the study of the regional markets.


1. Overview
1.1 Human Growth Hormone
Table 1: hGH Secretion Control
1.2 Physiological Effects of hGH
Table 2: hGH’s Physiological Effect
1.3 GH Deficiency (GHD)
1.4 Recombinant Human Growth Hormone (rhGH)
1.5 hGH Market by Indications
Table 3: hGH Market Segmentation by Indication
2. Global hGH Market
2.1 Global hGH Market by Value
Table 4: Global hGH Market by Value (2014-2018)
2.2 Global hGH Market Forecast by Value
Table 5: Global hGH Market Forecast by Value (2019-2023)
2.3 Global hGH Market by Volume
Table 6: Global hGH Market by Volume (2014-2018)
2.4 Global hGH Market Forecast by Volume
Table 7: Global hGH Market Forecast by Volume (2019-2023)
2.5 Global hGH Market Share by Indication
Table 8: Global hGH Market Share by Indication (2018)
2.6 Global hGH Market by Indication
2.6.1 Global Pediatric GHD Market Forecast by Value (2018-2023)
Table 9: Global Pediatric GHD Market Forecast by Value (2018-2023)
2.6.2 Global Other GHD Market Forecast by Value (2018-2023)
Table 10: Global Other GHD Market Forecast by Value (2018-2023)
2.7 Global hGH Market Forecast by Therapeutics
2.7.1 Global TransCon GH Revenue Forecast by Value
Table 11: Global TransCon GH Revenue Forecast by Value (2022-2028)
2.7.2 Global Other LAGH Market Forecast by Value
Table 12: Global Other LAGH Market Forecast by Value (2022-2028)
2.8 Global hGH Market Forecast by Therapeutics
Table 13: Global hGH Market Forecast by Therapeutics (2028)
2.9 Global hGH Market by Therapeutics
Table 14: Global hGH Market Share by Daily Agents (2018)
2.10 Global hGH Market by Region
Table 15: Global hGH Market by Region (2018)
3. Regional Markets
3.1 The U.S.
3.1.1 The U.S. hGH Market Forecast by Value
Table 16: The U.S. hGH Market Forecast by Value (2018-2023)
3.1.2 The U.S. hGH Market by Indication
Table 17: The U.S. hGH Market by Indication (2018)
3.1.3 The U.S. Pediatric GH Market Forecast by Value
Table 18: The U.S. Pediatric GH Market Forecast by Value (2018-2023)
3.1.4 The U.S. Pediatric GH Market by Indication
Table 19: The U.S. Pediatric GH Market by Indication (2018)
3.1.5 The U.S. Pediatric GHD Market Forecast by Value
Table 20: The U.S. Pediatric GHD Market Forecast by Value (2018-2023)
3.1.6 The U.S. Other Pediatric Indications Market Forecast by Value
Table 21: The U.S. Other Pediatric Indications Market Forecast by Value (2018-2023)
3.1.7 The U.S. Adult GHD Market Forecast by Value
Table 22: The U.S. Adult GHD Market Forecast by Value (2018-2023)
3.1.8 The U.S. Adult GHD Market Forecast by Value
Table 23: The U.S. Adult GHD Market Forecast by Value (2018-2023)
3.1.9 The U.S. Pediatric GHD Patient Population Forecast
Table 24: The U.S. Pediatric GHD Patient Population Forecast (2018-2023)
3.1.10 The U.S. Pediatric GHD Patient Population by Type
Table 25: The U.S. Pediatric GHD Patient Population by Type (2018)
3.1.11 The U.S. TransCon Revenue Forecast
Table 26: The U.S. TransCon Revenue Forecast (2021-2028)
3.2 Europe
3.2.1 Europe hGH Market Forecast by Value
Table 27: Europe hGH Market Forecast by Value (2018-2023)
3.2.2 Europe hGH Market by Indication
Table 28: Europe hGH Market by Indication (2018)
3.2.3 Europe Pediatric GHD Patient Population Forecast
Table 29: Europe Pediatric GHD Patient Population Forecast (2018-2023)
3.2.4 Europe Pediatric GHD Patient Population by Type
Table 30: Europe Pediatric GHD Patient Population by Type (2018)
3.2.5 Europe TransCon Revenue Forecast
Table 31: Europe TransCon Revenue Forecast (2023-2028)
3.3 Japan
3.3.1 Japan hGH Market Forecast by Value
Table 32: Japan hGH Market Forecast by Value (2018-2023)
3.3.2 Japan hGH Market by Indication
Table 33: Japan hGH Market by Indication (2018)
3.3.3 Japan Pediatric GHD Patient Population Forecast
Table 34: Japan Pediatric GHD Patient Population Forecast (2018-2023)
3.3.4 Japan Pediatric GHD Patient Population by Type
Table 35: Japan Pediatric GHD Patient Population by Type (2018)
3.3.5 Japan TransCon Revenue Forecast
Table 36: Japan TransCon Revenue Forecast (2023-2028)
4. Global Human Growth Hormone Market Opportunity
4.1 VRS-317
4.1.1 VRS-317 – The U.S. Growth Hormone Deficiency Market
Table 37: The U.S. Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2024)
4.1.2 VRS-317 – European Union (EU) Growth Hormone Deficiency Market
Table 38: EU Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2024)
4.1.3 VRS-317 –Japan Growth Hormone Deficiency Market
Table 39: Japan Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2020-2024)
4.2 TransCon hGH
4.2.1 TransCon hGH –The US, Europe and Japan/ROW Growth Hormone Deficiency Market
Table 40: The U.S., Europe & Japan/ROW Growth Hormone Deficiency Market of TransCon hGH (2021-2024)
4.2.2 Clinical Development Timeline for TransCon hGH
Table 41: Clinical Development Timeline for TransCon hGH (2018)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Incidence of Cancer Cases
Table 42: Global New Cancer Patients by Volume (2014-2018)
5.1.2 Rise in GDP Per Capita
Table 43: Global GDP Per Capita (2014-2018)
5.1.3 Increased Spending on Medicines
Table 44: Global Spending on Medicines (2010-2022)
5.1.4 Increasing Global Healthcare Expenditure
Table 45: Global Healthcare Expenditure (2014-2018)
5.1.5 Long-Acting hGH Agents in Development
Table 46: Global Late Stage Long-Acting Growth Hormone In Progress (2018)
5.1.6 Increasing Pituitary Dysfunctional Cases
5.2 Trends & Development
5.2.1 Use of TransCon Technology
5.2.2 Development of Auto-Injectors
5.2.3 Use of hGH as an Anti-Aging Therapy
5.3 Challenges
5.3.1 High Cost of Treatment
Table 47: Average Annual Cost of hGH Therapy for Children and Adults
5.3.2 High R&D Costs
5.3.3 Side Effects of rhGH
5.3.4 Low Share of Biosimilar
6. Competitive Landscape
6.1 Global hGH Market
6.1.1 Global hGH Market Volume Share by Company
Table 48: Global hGH Market Volume Share by Company (2018)
6.1.2 Global Long-Acting Growth Hormone Landscape by Company
Table 49: Global Long-Acting Growth Hormone Landscape by Company (2018)
6.2 The U.S. hGH Market
6.2.1 The U.S. hGH Market Value Share by Company
Table 50: The U.S. hGH Market Value Share by Company (2018)
7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
Table 51: Novartis International AG Sales by Segment (2018)
7.1.2 Financial Overview
Table 52: Novartis Net Sales and Net Income (2014-2018)
7.1.3 Business Strategies
7.2 Pfizer, Inc.
7.2.1 Business Overview
Table 53: Pfizer Inc. Revenue by Segment (2018)
7.2.2 Financial Overview
Table 54: Pfizer Inc. Revenue and Net Income (2014-2018)
7.2.3 Business Strategies
Table 55: Pfizer Inc. R&D Expenditure (2016-2018)
7.3 Eli Lilly and Company
7.3.1 Business Overview
Table 56: Eli Lilly and Company Revenue by Segments (2018)
7.3.2 Financial Overview
Table 57: Eli Lilly and Company Revenue and Net Income (2014-2018)
7.3.3 Business Strategies
Table 58: Eli Lilly and Company Research and Development Expenditure (2016-2018)
7.4 Novo Nordisk A/S
7.4.1 Business Overview
Table 59: Novo Nordisk A/S Net Sales by Business Segment (2018)
7.4.2 Financial Overview
Table 60: Novo Nordisk A/S Net Sales and Net Profit (2014-2018)
7.4.3 Business Strategies
Table 61: Novo Nordisk A/S R&D Expenditure (2016-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report